Ifp Advisors, Inc Akebia Therapeutics, Inc. Transaction History

Ifp Advisors, Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 12, 2022	SELL	$2.26 - $3.34 $343 - $507	-152 Closed	0 $0
Q3 2021 Oct 06, 2021	BUY	$2.35 - $3.88 $117 - $194	50 Added 49.02%	152 $1,000
Q2 2021 Jul 13, 2021	BUY	$2.83 - $4.2 $288 - $428	102 New	102 $0
Q1 2021 Apr 30, 2021	BUY	$2.92 - $5.06 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	SELL	$2.22 - $3.78 $104 - $177	-47 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$2.39 - $13.08 $112 - $614	47 New	47 $0
Q3 2018 Oct 25, 2018	SELL	$7.44 - $10.65 $208 - $298	-28 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$9.15 - $11.34 $3,660 - $4,536	-400 Reduced 93.46%	28 $0
Q1 2018 Jun 03, 2019	BUY	$9.53 - $15.68 $3,811 - $6,272	400 Added 1428.57%	428 $6,000
Q1 2018 May 09, 2018	SELL	$9.53 - $15.68 $3,811 - $6,272	-400 Reduced 93.46%	28 $0
Q4 2017 Jan 24, 2018	BUY	$14.24 - $19.59 $5,696 - $7,836	400 Added 1428.57%	428 $0
Q4 2016 Jun 03, 2019	BUY	N/A	28	28 $0

120

54.8M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $324M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.